These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24023332)

  • 21. [A Case of Sigmoid Colon Cancer with Synchronous Liver Metastasis, Treated with Laparoscopic Liver Resection after SOX plus BV Chemotherapy].
    Shimizu Y; Ando K; Oda K; Kubosawa H; Miyazaki M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2163-5. PubMed ID: 26805298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Severe Liver Injury Due to Sinusoidal Obstruction Syndrome Induced by Oxaliplatin in a Patient with Resectable Colorectal Liver Metastases].
    Tominaga K; Kurumiya Y; Sekoguchi E; Kobayashi S; Kawai K; Kiriyama M
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):989-992. PubMed ID: 30026429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatic resection after systemic chemotherapy for liver metastasis of colorectal cancer].
    Nishigaki T; Ide Y; Murata K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2566-8. PubMed ID: 21224641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase 1 study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases.
    Takahashi M; Hasegawa K; Oba M; Saiura A; Arita J; Sakamoto Y; Shinozaki E; Mizunuma N; Matsuyama Y; Kokudo N
    Invest New Drugs; 2016 Aug; 34(4):468-73. PubMed ID: 27155613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of circulating tumor cells for prediction of recurrent colorectal cancer progression.
    Kawahara H; Watanabe K; Toyama Y; Yanagisawa S; Kobayashi S; Yanaga K
    Hepatogastroenterology; 2012 Oct; 59(119):2115-8. PubMed ID: 22328299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001).
    Ozawa M; Watanabe J; Ishibe A; Goto K; Fujii Y; Nakagawa K; Suwa Y; Suwa H; Masui H; Sugita M; Mochizuki Y; Yamagishi S; Hasegawa S; Homma Y; Momiyama M; Kumamoto T; Matsuyama R; Takeda K; Taguri M; Endo I
    Cancer Chemother Pharmacol; 2024 Jun; 93(6):565-573. PubMed ID: 38374403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A Case of Rhabdomyolysis Related to SOX Therapy for Liver Metastasis of Gastric Cancer].
    Sato K; Akiyama H; Kogure Y; Suwa Y; Momiyama M; Ishibe A; Endo I
    Gan To Kagaku Ryoho; 2017 Apr; 44(4):329-331. PubMed ID: 28428515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
    Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
    Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver-directed chemotherapy of cetuximab and bevacizumab in combination with oxaliplatin is more effective to inhibit tumor growth of CC531 colorectal rat liver metastases than systemic chemotherapy.
    Sperling J; Brandhorst D; Schäfer T; Ziemann C; Benz-Weißer A; Scheuer C; Kollmar O; Schilling MK; Menger MD
    Clin Exp Metastasis; 2013 Apr; 30(4):447-55. PubMed ID: 23187934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus.
    Cheng AL; Li J; Vaid AK; Ma BB; Teh C; Ahn JB; Bello M; Charoentum C; Chen LT; de Lima Lopes G; Ho GF; Kong HL; Lam KO; Liu TS; Park YS; Sriuranpong V; Sudoyo AW; Wang JY; Zhang J; Zhang SZ; Ciardiello F; Köhne CH; Shaw M; Kim TW
    Clin Colorectal Cancer; 2014 Sep; 13(3):145-55. PubMed ID: 25209093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Complete resection of liver metastases of colorectal cancer after high efficacy bevacizumab, S-1, and CPT -11 combination chemotherapy].
    Imai H; Sawada K; Sato A; Nishi K; Sasaki T; Takahashi T; Ohori H
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):101-4. PubMed ID: 25596689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 study.
    Sogabe S; Komatsu Y; Yuki S; Kusumi T; Hatanaka K; Nakamura M; Kato T; Miyagishima T; Hosokawa A; Iwanaga I; Sakata Y; Asaka M
    Jpn J Clin Oncol; 2011 Apr; 41(4):490-7. PubMed ID: 21303790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical study of tegafur-gimeracil-oteracil potassium capsule (s-1) and oxaliplatin combination chemotherapy in advanced colorectal cancer.
    Liu H; Wang Y; Li G; Song W; Wang R
    J Cancer Res Ther; 2015; 11(2):331-5. PubMed ID: 26148595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of oxaliplatin and S-1 versus sorafenib alone in patients with advanced hepatocellular carcinoma.
    Lv Y; Liang R; Hu X; Liu Z; Liao X; Lin Y; Yuan C; Liao S; Li Q; Zhang J; Li Y
    Pharmazie; 2014 Oct; 69(10):759-63. PubMed ID: 25985566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOLFOX plus cetuximab for a patient with metastatic colorectal cancer with icterus due to multiple liver metastases.
    Mizota A; Shitara K; Kondo C; Nomura M; Yokota T; Takahari D; Ura T; Muro K
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1205-8. PubMed ID: 21772113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of addition of bevacizumab to oxaliplatin-based preoperative chemotherapy in colorectal cancer with liver metastasis- a single institution experience.
    Cvetanovic A; Vrbic S; Filipovic S; Pejcic I; Milenkovic D; Milenkovic N; Zivkovic N
    J BUON; 2013; 18(3):641-6. PubMed ID: 24065477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between response to chemotherapy with concomitant bevacizumab for hepatic metastasis of colorectal cancer and degree of enhancement using contrast-enhanced computed tomography.
    Osawa G; Yoshimatsu K; Yokomizo H; Okayama S; Sagawa M; Naritaka Y
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):209-15. PubMed ID: 23670642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy.
    Adam R; Aloia T; Lévi F; Wicherts DA; de Haas RJ; Paule B; Bralet MP; Bouchahda M; Machover D; Ducreux M; Castagne V; Azoulay D; Castaing D
    J Clin Oncol; 2007 Oct; 25(29):4593-602. PubMed ID: 17925554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative chemotherapy with a trastuzumab-containing regimen for a patient with gastric cancer and hepatic metastases.
    Li ZY; Shan F; Zhang LH; Bu ZD; Wu AW; Wu XJ; Zong XL; Li SX; Ji X; Ji JF
    Genet Mol Res; 2014 Dec; 13(4):10952-7. PubMed ID: 25526216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.